INIS
humans
100%
rats
100%
injuries
100%
bone marrow
100%
spinal cord
100%
in vitro
37%
doses
25%
applications
25%
motors
25%
recovery
25%
expansion
25%
testing
12%
levels
12%
injection
12%
males
12%
clinical trials
12%
stem cells
12%
performance
12%
surveillance
12%
adults
12%
neurons
12%
Keyphrases
Human Mesenchymal Stem Cells (hMSCs)
100%
Treatment Delay
100%
Spinal Cord Injury
100%
Improved Efficacy
100%
Negative Selection
37%
Expansion in Vitro
25%
Clinical Trials
12%
Dose Effect
12%
Functional Impact
12%
Therapeutic Effect
12%
Histological Analysis
12%
Adult Male
12%
Wistar Rats
12%
Stem Cells
12%
Motor Performance
12%
Axonal Degeneration
12%
Spinal Cord
12%
Oligodendrocyte
12%
Motor Recovery
12%
Intrathecal Application
12%
Spinal Cord Contusion Injury
12%
Cisterna Magna
12%
Delayed Application
12%
Thoracic Level
12%
Medicine and Dentistry
Spinal Cord Injury
100%
Stromal Cell
100%
In Vitro
37%
Motor Performance
25%
Clinical Trial
12%
Therapy Effect
12%
Contusion
12%
Nerve Fiber Degeneration
12%
Stem Cell
12%
Cisterna Magna
12%
Oligodendrocyte
12%
Hexachlorophene
12%
Veterinary Science and Veterinary Medicine
Rat
100%
Stromal Cell
100%
Spinal Cord Injury
100%
Stem Cell
12%
Oligodendrocyte
12%
Cisterna Magna
12%
Neuroscience
Spinal Cord Injury
100%
In Vitro
75%
Stem Cell
25%
Nerve Fiber Degeneration
25%
Axonal Degeneration
25%
Oligodendrocyte
25%
Intrathecal
25%
Cisterna Magna
25%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Wistar Rat
25%
Clinical Trial
25%
Therapeutic Effect
25%
Contusion
25%
Nerve Fiber Degeneration
25%
Intrathecal
25%
Hexachlorophene
25%
Biochemistry, Genetics and Molecular Biology
Stromal Cell
100%
Motor Performance
25%
Stem Cell
12%
Wistar Rat
12%
Clinical Trial
12%
Nerve Fiber Degeneration
12%
Oligodendrocyte
12%